Cerebrospinal Fluid Leak Clinical Trial
Official title:
International Opinion Study on Peri-operative Cerebrospinal Fluid Leaks Management After Endoscopic Skull Base Surgery
Verified date | September 2019 |
Source | University Hospital, Montpellier |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Cerebrospinal fluid (CSF) leak is a rare condition. When it involves the ventral skull base,
a surgical closure may be achieved using endoscopic skull base surgery techniques. The major
principles remain in achieving a watertight closure that can also support the brain (and
avoid brain sagging) in case of extensive skull base defects. Surgical techniques are well
described. Many clinical factors may influence the successful rate of the reconstruction.
However, there is a lack of clinical study on perioperative management of CSF leaks. The
purpose of this study is to gather the opinion of skull base surgeons on the post-operative
management of patients to avoid CSF leak recurrence.
•Methods: The investigators will collect data from skull base surgeons using an electronic
survey questionnaire (Google Form, Google, Mountain View, California, U.S.A.) submitted by
e-mail to the members of the French Association of Rhinology, to the European Rhinologic
Society, to the French college of neurosurgeons, to the Italian skull base society members,
and to the former students of the European endoscopic skull base diploma. This is an
anonymous 60-items survey. Questions were classified in eight sections: general questions,
material used at the end of the surgical procedure, post-operative resting position, drugs,
CSF depletion, post-operative advices, explorations in case of early recurrence of the
rhinorrhoea, and follow-up modalities.
•Discussion: The investigators aim to understand the actual practice of skull base surgeons
after closure of ventral skull base CSF leaks. This can serve as a basis for conducting
clinical studies in the future.
Status | Completed |
Enrollment | 153 |
Est. completion date | October 1, 2019 |
Est. primary completion date | September 1, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years and older |
Eligibility |
Inclusion criteria An individual must fulfill all of the following criteria in order to be eligible for study enrollment: - Active skull base surgery practice (ENT surgeon or neurosurgeon) - Volunteering Non inclusion criteria - Subject unable to read or/and write - Undergraduate students - Refusal to participate |
Country | Name | City | State |
---|---|---|---|
France | Uh Montpellier | Montpellier |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Montpellier |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of perioperative management of CSF leaks | Evaluation of perioperative management of CSF leaks at pre-treatment (preoperative) with 60 items questionnaire (QCM) | 1 day (pre-treatment) | |
Primary | Evaluation of perioperative management of CSF leaks | Evaluation of perioperative management of CSF leaks at the end of the surgery with 60 items questionnaire (QCM) | 1 day (the end of the surgery) | |
Primary | Evaluation of perioperative management of CSF leaks | Evaluation of perioperative management of CSF leaks during hospitalization with 60 items questionnaire (QCM) | maximum 2 weeks (during hospitalization) | |
Secondary | Comparison of practices of surgeons according by specialties | Comparison of practices of surgeons according by specialties at pre-treatment (preoperative) with 60 items questionnaire (QCM) | 1 day (pre-treatment) | |
Secondary | Comparison of practices of surgeons according by specialties | Comparison of practices of surgeons according by specialties at the end of the surgery with 60 items questionnaire (QCM) | 1 day (the end of the surgery) | |
Secondary | Comparison of practices of surgeons according by specialties | Comparison of practices of surgeons according by specialties during hospitalization with 60 items questionnaire (QCM) | maximum 2 weeks (during hospitalization) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04057157 -
Post-market Assessment of Biodesign Dural Repair Grafts
|
||
Withdrawn |
NCT02902133 -
Acetazolamide to Prevent Post Operative CSF Leak
|
Phase 2 | |
Recruiting |
NCT02927782 -
Mobilisation Algorithm After Incidental Durotomy
|
N/A | |
Completed |
NCT03566602 -
Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
|
N/A | |
Completed |
NCT02891070 -
Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery
|
Phase 3 | |
Recruiting |
NCT04490629 -
The Efficacy and Safety of a Latest Dural Substitute
|
N/A | |
Withdrawn |
NCT04351061 -
Acetazolamide for the Prevention of Post Operative CSF Leak
|
Phase 2 | |
Recruiting |
NCT04086550 -
Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
|
N/A | |
Completed |
NCT02457546 -
The EVICEL® Neurosurgery Phase III Study
|
Phase 3 | |
Completed |
NCT04145544 -
A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.
|
N/A | |
Active, not recruiting |
NCT04923867 -
Suturable DuraGen™ PMCF Study
|
||
Withdrawn |
NCT03181464 -
Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics
|
Phase 4 |